Ever Source Wealth Advisors, LLC Merus N.V. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Merus N.V. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 15 shares of MRUS stock, worth $840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15
Previous 2
650.0%
Holding current value
$840
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MRUS
# of Institutions
195Shares Held
62.2MCall Options Held
355KPut Options Held
96.5K-
Wellington Management Group LLP Boston, MA4.72MShares$264 Million0.04% of portfolio
-
Commodore Capital LP New York, NY4.47MShares$251 Million18.43% of portfolio
-
Rtw Investments, LP New York, NY4.17MShares$234 Million2.88% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.37MShares$189 Million7.27% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.17MShares$178 Million3.38% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $2.57B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...